/

Other

/

Organon

Organon

Organon

Verified Nov 2026

Other

·

United States flag

Jersey City, New Jersey

·

Since

Organon is a global healthcare company headquartered in Jersey City, New Jersey, established in June 2021 as a spin-off from Merck & Co. With 10,000–50,000 employees and estimated revenue of $5–10 billion, it operates in approximately 140 markets. The company manufactures over 60 medicines and products across reproductive health, psychiatry, hormone replacement therapy, and anesthesia. In September 2026, the FDA accepted for review a supplemental application for MIUDELLA, a hormone-free intrauterine device Organon licensed from Sebela Pharmaceuticals.

Organon

Verified Nov 2026

AT A GLANCE

Founded

Headquarters

United States flag

Jersey City, New Jersey

Employees

10,000-50,000

Ownership

Organon at a glance

Revenue

$5-10B

Est. band

Employees

10,000-50,000

Headquarters

Jersey City, New Jersey

Certifications

ISO 9001

Import activity

157

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

157

Named foreign suppliers

15

Top origins

Netherlands · Belgium · Mexico · United Kingdom

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Organon.

What this tells a buyer

Customs records document 157 shipments across multiple origins including the Netherlands, Belgium, Mexico, United Kingdom, Singapore, Italy, and Hong Kong, with significant inbound flows from affiliated entities in Switzerland and the United Kingdom.

The company holds ISO 9001 certification and operates six manufacturing facilities to produce prescription medicines, biosimilars, and medical devices across multiple therapeutic areas.

In April 2026, Sun Pharma signed a definitive agreement to acquire Organon, marking a significant transition in company ownership.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

157 US import shipments on record.

Holds ISO 9001 certification(s) per public sources.

Overview

Organon is a global healthcare company headquartered in Jersey City, New Jersey, established in June 2021 as a spin-off from Merck & Co. With 10,000–50,000 employees and estimated revenue of $5–10 billion, it operates in approximately 140 markets. The company manufactures over 60 medicines and products across reproductive health, psychiatry, hormone replacement therapy, and anesthesia. In September 2026, the FDA accepted for review a supplemental application for MIUDELLA, a hormone-free intrauterine device Organon licensed from Sebela Pharmaceuticals.

At a glance

Attribute

Detail

Headquarters

Jersey City, New Jersey

Employees

10,000-50,000

Revenue

$5-10B (estimated)

Certifications

ISO 9001

What Organon makes

The company holds ISO 9001 certification and operates six manufacturing facilities to produce prescription medicines, biosimilars, and medical devices across multiple therapeutic areas.

Products and capabilities described on the company's own site include Assembly (source: organon.com).

Certifications

Organon is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

Customs records document 157 shipments across multiple origins including the Netherlands, Belgium, Mexico, United Kingdom, Singapore, Italy, and Hong Kong, with significant inbound flows from affiliated entities in Switzerland and the United Kingdom. US customs bill-of-lading records list 157 inbound shipments across 15 foreign suppliers, with top origins including Netherlands · Belgium · Mexico · United Kingdom.

Latest developments

Company details

In April 2026, Sun Pharma signed a definitive agreement to acquire Organon, marking a significant transition in company ownership. Organon has an estimated 10,000-50,000 employees, and is headquartered in Jersey City, New Jersey. On the LightSource stability read it is rated "Established & active": 157 US import shipments on record. Holds ISO 9001 certification(s) per public sources.

Frequently asked questions

What does Organon do?

Organon is a global healthcare company headquartered in Jersey City, New Jersey, established in June 2021 as a spin-off from Merck & Co. With 10,000–50,000 employees and estimated revenue of $5–10 billion, it operates in approximately 140 markets. The company manufactures over 60 medicines and products across reproductive health, psychiatry, hormone replacement therapy, and anesthesia. In September 2026, the FDA accepted for review a supplemental application for MIUDELLA, a hormone-free intrauterine device Organon licensed from Sebela Pharmaceuticals.

Where is Organon headquartered?

Organon is headquartered in Jersey City, New Jersey (30 Hudson Street, Jersey City, New Jersey, 07302).

How big is Organon?

Organon has an estimated 10,000-50,000 employees, with revenue in the $5-10B range (estimated).

What certifications does Organon hold?

Organon lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Does Organon import from overseas suppliers?

US customs bill-of-lading records show 157 inbound shipments for Organon, with top origins including Netherlands · Belgium · Mexico · United Kingdom.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Jersey City, New Jersey (HQ)Headquarters · United States
Jersey City, New Jersey (HQ)30 Hudson Street, Jersey City, New Jersey, 07302, United StatesHeadquarters

Phone

'+1 551-430-6000

Certification

ISO 9001

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.